2m 2m 2m 2m 2m 2m 2m
NovoCure NPV (NVCR)
NASDAQ
$14.96+$0.12 (+0.81%)
Price as of Aug 03, 2026 8:31 AM EDT- $1.7BMarket Cap
- 31.10%1-Year Change
- Medical DevicesIndustry
NovoCure NPV (NVCR)
$14.96+$0.12 (+0.81%)
NVCR | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $14.84 | ||
Change | -$0.39 (-2.56%) | ||
Open | $15.46 | ||
High | $15.72 | ||
Low | $14.83 | ||
Previous Close | $15.23 | ||
Volume | 1,228,737 | ||
30-Day Average Volume | 1,852,263 | ||
1-Week Change | -15.92% | ||
1-Month Change | -2.05% | ||
1-Year Change | 31.10% | ||
3-Year Change | -54.53% | ||
5-Year Change | -90.36% | ||
Fundamentals | |||
Shares Outstanding | 111.5M | ||
Total Assets | $795.2M | ||
Market Cap | $1.7B | ||
Enterprise Value | $1.8B | ||
Period: QTR TTM FY | |||
Revenue | $183.6M | ||
Net Income | -$15.7M | ||
Free Cash Flow | $1.2M | ||
EBIT | -$10.6M | ||
EBITDA | -$6.3M | ||
Net Working Capital | $417.8M | ||
EPS | -$0.13 | ||
Enterprise Value/EBITDA | -281 | ||
Enterprise Value/Revenue | 10 | ||
P/B | 5 | ||
P/E | -114 | ||
PEG | -1 | ||
Price/Free Cash Flow | 1,361 | ||
Price/Operating Cash Flow | 203 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue